Compare Edgewise Therapeutics Inc. Common Stock (EWTX) vs Vir Biotechnology Inc. Common Stock (VIR) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Edgewise Therapeutics Inc. Common Stock vs Vir Biotechnology Inc. Common Stock — how do they compare? Edgewise Therapeutics Inc. Common Stock trades at $37.32 (market cap $3.94B), while Vir Biotechnology Inc. Common Stock trades at $10.2 (market cap $1.80B). The key difference: Edgewise Therapeutics Inc. Common Stock is far larger — about 2.2× Vir Biotechnology Inc. Common Stock's market cap, and Edgewise Therapeutics Inc. Common Stock is more actively traded (810,104 versus 1,782,836). Which is the better fit depends on your goals — on Pluang, investors hold Edgewise Therapeutics Inc. Common Stock for 0 Days and Vir Biotechnology Inc. Common Stock for 0 Days on average.
| EWTX | VIR | |
|---|---|---|
Market Cap | $3.94B | $1.80B |
Volume | 810,104 | 1,782,836 |
Sector | Health | Health |
52-Week High | $48.35 | $11.78 |
52-Week Low | $14.89 | $5.12 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $3.48B | $1.36B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Edgewise Therapeutics Inc. Common Stock
Edgewise Therapeutics, Inc. is a clinical-stage biopharmaceutical company that develops small-molecule therapies based on its research in muscle physiology, with a pipeline focused on cardiovascular and cardiometabolic conditions such as hypertrophic cardiomyopathy and heart failure.
Read more on EWTX →About Vir Biotechnology Inc. Common Stock
Vir Biotechnology, Inc. is a US clinical-stage biopharmaceutical company that develops monoclonal antibody-based medicines to treat and prevent serious infectious diseases.
Read more on VIR →
